By Traci Pedersen
There is a serious lack of new drug treatments for mental health disorders, such as depression and schizophrenia, say leading international academics, who are currently advocating for new approaches to drug development for mental health disorders.
Although nearly 40 percent of the population is affected by mental health issues, which includes everything from depression and dementia to anxiety and schizophrenia, researchers say there is still a crisis in the development of new treatments.
“The pharmaceutical industry has in part withdrawn, either because they struggled to translate research into a viable drug or because of financial pressures. Although some have remained, there are still insufficient resources being focused on diseases which affect a disproportionate percentage of the population,” said Professor Barbara Sahakian, of the Department of Psychiatry at the University of Cambridge.